Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking the MARS imaging system for its applications in medical diagnosis.
The MARS imaging system is based on the new generation Medipix chip licensed out of CERN, Switzerland and technology developed by the University of Canterbury (UC) and partners. It has established itself as the world’s leading spectral (multi-energy ‘true colour’) imaging technology. It is the first commercially available spectral, high definition computed tomography (CT) system and has already demonstrated exciting applications.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 106 Wrights Road, Level 2,new Zealand
- sp****@****ing.com
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- marsbioimaging.com
- Keywords
- Christchurch.
- HQ
- Christchurch, Canterbury
Mars Bioimaging Ltd Questions
Mars Bioimaging Ltd's website is marsbioimaging.com
Mars Bioimaging Ltd's LinkedIn profile is https://nz.linkedin.com/company/mars-bioimaging-ltd
Mars Bioimaging Ltd has
16 employees.
View email and phone details for 16
employees at Mars Bioimaging Ltd.
Mars Bioimaging Ltd's industry is
Research Services
Mars Bioimaging Ltd's top competitors are
Cmiv - Center For Medical Image Science And Visualization,
Mainland Angel Investors,
Basis,
Volpara Health,
Enztec,
Ge Healthcare,
Argus Manutech,
Syft Technologies,
Cern,
Mastaplex.
Mars Bioimaging Ltd's support email address is spectroscopy@marsbioimaging.com
Mars Bioimaging Ltd's categories are Research Services
Mars Bioimaging Ltd's founding year is 2007
